SI1373255T1 - - Google Patents

Info

Publication number
SI1373255T1
SI1373255T1 SI200230100T SI200230100T SI1373255T1 SI 1373255 T1 SI1373255 T1 SI 1373255T1 SI 200230100 T SI200230100 T SI 200230100T SI 200230100 T SI200230100 T SI 200230100T SI 1373255 T1 SI1373255 T1 SI 1373255T1
Authority
SI
Slovenia
Application number
SI200230100T
Inventor
Walter Ferdinand Mari Filliers
Rudy Laurent Maria Broeckx
Stefan Marcel Herman Leurs
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SI1373255T1 publication Critical patent/SI1373255T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
SI200230100T 2001-03-12 2002-03-05 SI1373255T1 (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01200928 2001-03-12
PCT/EP2002/002459 WO2002072574A1 (en) 2001-03-12 2002-03-05 Process for the preparation of imidazole compounds
EP02722184A EP1373255B1 (en) 2001-03-12 2002-03-05 Process for the preparation of imidazole compounds

Publications (1)

Publication Number Publication Date
SI1373255T1 true SI1373255T1 (he) 2005-08-31

Family

ID=8180004

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230100T SI1373255T1 (he) 2001-03-12 2002-03-05

Country Status (32)

Country Link
US (1) US6844439B2 (he)
EP (1) EP1373255B1 (he)
JP (1) JP4257698B2 (he)
KR (1) KR100849042B1 (he)
CN (1) CN1246318C (he)
AR (1) AR035944A1 (he)
AT (1) ATE287882T1 (he)
AU (1) AU2002253101B2 (he)
BR (1) BRPI0208075B8 (he)
CA (1) CA2438421C (he)
CZ (1) CZ300622B6 (he)
DE (1) DE60202755T2 (he)
DK (1) DK1373255T3 (he)
EA (1) EA006770B1 (he)
EE (1) EE05247B1 (he)
ES (1) ES2236505T3 (he)
HK (1) HK1063315A1 (he)
HR (1) HRP20030695B1 (he)
HU (1) HU230282B1 (he)
IL (2) IL157839A0 (he)
MX (1) MXPA03008205A (he)
MY (1) MY124838A (he)
NO (1) NO324954B1 (he)
NZ (1) NZ528620A (he)
PL (1) PL208238B1 (he)
PT (1) PT1373255E (he)
SI (1) SI1373255T1 (he)
SK (1) SK287807B6 (he)
TW (1) TWI249532B (he)
UA (1) UA74871C2 (he)
WO (1) WO2002072574A1 (he)
ZA (1) ZA200307117B (he)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072090A1 (en) 2001-03-12 2002-09-19 Avanir Pharmaceuticals Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
CA2559221A1 (en) * 2004-03-18 2005-09-29 Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
JP5008554B2 (ja) * 2004-05-03 2012-08-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ イミダゾール化合物の製造用のジアステレオ選択的合成方法
ES2346986T3 (es) * 2004-05-03 2010-10-22 Janssen Pharmaceutica Nv Proceso de sintesis diastereoselectiva con 6-bromo-4-(3-clorofenil)-2-methoxi-quinolina.
JP4917021B2 (ja) * 2004-05-03 2012-04-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルフィンイミン類に対するリチオ化されたn−メチルイミダゾールのジアステレオ選択的付加
EP2545919A1 (en) 2005-12-23 2013-01-16 Link Medicine Corporation Treatment of synucleinopathies
WO2009151683A2 (en) * 2008-03-12 2009-12-17 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
KR101044430B1 (ko) * 2009-09-25 2011-06-27 듀오백코리아 주식회사 요추받이를 포함하는 의자의 등 지지 장치
KR101107900B1 (ko) * 2009-10-21 2012-01-25 성용기업 주식회사 의자용 허리지지장치
TWI710642B (zh) 2015-08-17 2020-11-21 美商庫拉腫瘤技術股份有限公司 以法呢基轉移酶(farnesyltransferase)抑制劑治療癌症病患之方法
CA3042747A1 (en) 2016-11-03 2018-05-11 Kura Oncology, Inc. Methods of treating cancer patients with farnesyltransferase inhibitors
US10954210B2 (en) 2016-12-08 2021-03-23 Hangzhou Solipharma Co., Ltd. Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof
US11542244B2 (en) * 2018-05-18 2023-01-03 Kura Oncology, Inc. Synthesis of tipifarnib

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW349948B (en) 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
WO1997021701A1 (en) * 1995-12-08 1997-06-19 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
TW591030B (en) * 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
CA2288140C (en) 1997-04-25 2007-04-03 Janssen Pharmaceutica N.V. Farnesyltransferase inhibiting quinazolinones
ID27562A (id) * 1998-08-27 2001-04-12 Pfizer Prod Inc Turunan-turunan kinolin-2-ona tersubstitusi alkunil yang berguna sebagai zat anti kanker
EP1107962B1 (en) 1998-08-27 2005-02-23 Pfizer Products Inc. Quinolin-2-one derivatives useful as anticancer agents

Also Published As

Publication number Publication date
AR035944A1 (es) 2004-07-28
MXPA03008205A (es) 2004-01-29
EA200300998A1 (ru) 2004-02-26
SK12462003A3 (sk) 2004-06-08
IL157839A (he) 2008-07-08
DE60202755D1 (de) 2005-03-03
JP4257698B2 (ja) 2009-04-22
WO2002072574A1 (en) 2002-09-19
CN1496363A (zh) 2004-05-12
CZ300622B6 (cs) 2009-07-01
EP1373255B1 (en) 2005-01-26
ZA200307117B (en) 2004-09-13
PL363263A1 (en) 2004-11-15
HRP20030695B1 (en) 2011-07-31
US20040138256A1 (en) 2004-07-15
BRPI0208075B8 (pt) 2021-05-25
US6844439B2 (en) 2005-01-18
EE200300442A (et) 2003-12-15
KR20030079971A (ko) 2003-10-10
EA006770B1 (ru) 2006-04-28
HU230282B1 (hu) 2015-12-28
EP1373255A1 (en) 2004-01-02
JP2004523575A (ja) 2004-08-05
HRP20030695A2 (en) 2005-02-28
MY124838A (en) 2006-07-31
AU2002253101B2 (en) 2007-08-09
HUP0303443A3 (en) 2012-09-28
TWI249532B (en) 2006-02-21
NO20034003L (no) 2003-10-22
SK287807B6 (sk) 2011-10-04
BR0208075A (pt) 2004-03-02
HK1063315A1 (en) 2004-12-24
KR100849042B1 (ko) 2008-07-29
NZ528620A (en) 2005-01-28
PT1373255E (pt) 2005-05-31
CA2438421A1 (en) 2002-09-19
EE05247B1 (et) 2009-12-15
UA74871C2 (en) 2006-02-15
PL208238B1 (pl) 2011-04-29
DE60202755T2 (de) 2006-03-30
ES2236505T3 (es) 2005-07-16
CZ20032704A3 (en) 2004-03-17
NO324954B1 (no) 2008-01-14
HUP0303443A2 (hu) 2004-01-28
NO20034003D0 (no) 2003-09-10
IL157839A0 (en) 2004-03-28
CN1246318C (zh) 2006-03-22
DK1373255T3 (da) 2005-05-23
ATE287882T1 (de) 2005-02-15
BRPI0208075B1 (pt) 2018-02-14
CA2438421C (en) 2010-05-18

Similar Documents

Publication Publication Date Title
BE2022C531I2 (he)
BE2022C502I2 (he)
BE2022C547I2 (he)
BE2017C057I2 (he)
BE2015C046I2 (he)
BE2014C052I2 (he)
BE2014C036I2 (he)
BE2014C026I2 (he)
BE2014C004I2 (he)
BE2014C006I2 (he)
BE2011C034I2 (he)
BE2007C047I2 (he)
AU2002307149A8 (he)
JP2002244803A5 (he)
JP2002020805A5 (he)
BRPI0209186B1 (he)
JP2002032003A5 (he)
BE2014C008I2 (he)
BRPI0204884A2 (he)
CH1379220H1 (he)
BE2017C059I2 (he)
DE60230025D1 (he)
JP2001346145A5 (he)
DE60238912D1 (he)
JP2002211385A5 (he)